J Korean Med Sci.  1998 Dec;13(6):652-657. 10.3346/jkms.1998.13.6.652.

Expression of osteopontin and osteonectin in breast cancer

• Kim YW
• Park YK
• Lee J
• Ko SW
• Yang MH

• KMID: 1038447
• DOI: http://doi.org/10.3346/jkms.1998.13.6.652

Abstract

Osteopontin (OP) and osteonectin (ON) are bone matrix proteins produced by mammary and other cancers. These proteins may play a role in tumor invasion and metastasis through integrin-mediated signal transduction. We evaluated expressions of OP and ON in 253 resected infiltrating ductal carcinoma of the breast, using immunohistochemical staining and follow-up data. OP and ON were detected 87.4% and 54.2% of 253 cases, respectively. The OP and ON positive staining were localized in the cytoplasm of carcinoma cells. OP and ON did not correlate with various clinicopathological parameters, such as age, lymph node involvement, tumor size, histologic grade, expression of p53 and estrogen receptor (ER). In the multivariate model, lymph node involvement and histologic grade were statistically significant prognostic factors. Assessed by a log rank test, the 5-year-survival rates of OP and ON positive groups and their negative groups were not statistically different. In conclusion, OP and ON immunopositivity of infiltrating ductal carcinomas of the breast provide no additional prognostic information in this study.

MeSH Terms

Adult
Breast Neoplasms/chemistry*
Carcinoma, Infiltrating Duct/chemistry*
Female
Follow-Up Studies
Human
Immunohistochemistry
Middle Age
Osteonectin/biosynthesis*
Protein p53/biosynthesis
Receptors, Estrogen/biosynthesis
Sialoglycoproteins/biosynthesis*